Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

2,679 public trials 158 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA)

NCT00866658

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +6 more
Locations
  • Sanofi-Aventis Administrative Office Tokyo, Japan
  • Sanofi-Aventis Administrative Office Makati City, Philippines
  • Sanofi-Aventis Administrative Office Seoul, South Korea
  • Sanofi-Aventis Administrative Office Taipei, Taiwan
View Trial Details
Completed

The TANTALUS® II for the Treatment of Type 2 Diabetes

NCT01303302

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Medical University of Vienna Vienna, Austria
  • Gemeinschaftspraxis Drs. Klausmann Aschaffenburg, Germany
  • Arzt für Innere Medizin und Endokrinologie Bad Nauheim, Germany
  • Krankenhaus Sachsenhausen Frankfurt, Germany
View Trial Details
Completed

A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

NCT01733758

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Chiba, Japan
  • GSK Investigational Site Ehime, Japan
  • GSK Investigational Site Ehime, Japan
View all 74 locations
View Trial Details

Related conditions